Filing Details
- Accession Number:
- 0001179110-12-002246
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-09 19:24:48
- Reporting Period:
- 2012-02-07
- Filing Date:
- 2012-02-09
- Accepted Time:
- 2012-02-09 19:24:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1198226 | Etienne Davignon | Suez-Tractebel 1 Place Du Trone Brussels C9 B-1000 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-02-07 | 12,000 | $55.26 | 600,391 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale prices reported for the transactions reported here range from $55.07 to $55.37. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Billionaire Hedge Funds
